Condition
Oligoprogressive clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Oligoprogressive clinical trials that are recruiting, at sites in 4 countries (most in United States (5), Canada (2), Belgium (1)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 4Countries
Newest Oligoprogressive clinical trials
All recruiting trials (9)
-
Treatment for prostate cancer with limited metastasis
This study is testing whether a new treatment for prostate cancer with a few spreading spots can help patients live longer by comparing radiotherapy to surgery.
-
Combining systemic therapy with local ablative treatments for certain lung cancers
This study is testing if adding local treatments to ongoing therapy can help people with certain lung cancers live longer without their disease getting worse.
-
Combining local ablative therapy with ongoing systemic treatment for certain cancers
This study is testing whether adding local treatments to ongoing cancer therapy can help people with certain solid tumors live longer without their disease getting worse.
-
Combining local therapies with systemic treatment for certain cancers
This study is testing if adding local treatments like targeted radiation or ablation can help people with certain types of cancer, such as prostate or kidney cancer, stay on their main treatment longer without needing changes.
-
Combining local therapy with ongoing systemic treatment for certain cancers
This study is testing whether adding local treatments to ongoing systemic therapy can help people with certain cancers keep their disease under control for longer.
-
Continuing systemic therapy after local treatment for metastatic breast cancer
This study is testing if continuing treatment after local therapies can help people with metastatic breast cancer feel better and live longer.
-
Stereotactic radiotherapy for patients with metastatic head and neck cancer showing limited progression
This study is testing if a special type of targeted radiation therapy can help people with metastatic head and neck cancer who are seeing limited disease progression while on other treatments.
-
Using targeted radiation therapy for patients with limited progression of kidney cancer on immune therapy
This study is testing if a special type of radiation therapy can help people with kidney cancer who are seeing limited growth while on immune therapy feel better and live longer.
-
Using targeted radiation therapy for prostate cancer that resists standard treatment
This study is testing a new type of targeted radiation therapy for men with prostate cancer that isn't responding to standard treatment, to see if it can help control their cancer while they continue their current medication.
Related topics
Quick answers
How many Oligoprogressive clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (5 trials), Canada (2 trials), Belgium (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.